KEVIN ERICKSON to Polycystic Kidney, Autosomal Dominant
This is a "connection" page, showing publications KEVIN ERICKSON has written about Polycystic Kidney, Autosomal Dominant.
Connection Strength
0.950
-
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2014 Jan 21; 160(2):143.
Score: 0.481
-
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2013 Sep 17; 159(6):382-9.
Score: 0.470